Press-release for stocks for glaxosmithkline plc

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | $92.966 630

| -0.01% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | $135.94 770

| 10.07% | O: 0.87% H: 0.21% C: -2.23%
GSK | $40.035 -1.15% 1.5M

| -2.15% | O: 0.89% H: 0.41% C: 0.1%
LLY | $749.215 -0.21% 1.4M

| 1.05% | O: 0.38% H: 2.44% C: 1.54%
VRTX | $394.73 -0.66% 370K

| -4.49% | O: 0.56% H: 0.49% C: -0.12%
SNY | $46.05 -0.41% 940K

| 1.52% | O: -1.1% H: 0.0% C: 0.0%
BIIB | $196.6 -0.1% 350K

| -13.17% | O: 0.16% H: 0.43% C: -2.76%
AZN | $68.38 -0.51% 2.1M

| 12.62% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $264.955 -0.21% 880K

| -8.6% | O: -0.21% H: 0.34% C: 0.07%
disease report treatment expansion global infections market

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 510

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | $135.94 770

| 12.66% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | $9.2715 500K

| -14.31% | O: 0.37% H: 0.74% C: 0.28%
TAK | $13.265 0.65% 1.6M

| -7.9% | O: 0.14% H: 0.35% C: 0.07%
NVS | $92.99 -1.5% 990K

| -6.09% | O: -0.34% H: 0.23% C: -1.13%
JNJ | $145.405 -1.48% 7.6M

| -5.76% | O: 0.7% H: 0.0% C: 0.0%
GSK | $40.035 -1.15% 1.5M

| -1.39% | O: 1.22% H: 0.07% C: -0.43%
LLY | $749.215 -0.21% 1.4M

| 1.83% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.365 -0.3% 4.9M

| -2.49% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $162.93 0.78% 3.1M

| -6.59% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $14.43 1.62% 300K

| -22.02% | O: -1.15% H: 1.03% C: -1.5%
VRTX | $394.73 -0.66% 370K

| -5.06% | O: -0.28% H: 0.49% C: -0.32%
SNY | $46.05 -0.41% 940K

| 1.45% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.42 6K

| -6.2% | O: -3.1% H: 1.2% C: -0.8%
INCY | $53.725 0.55% 630K

| -7.62% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $196.6 -0.1% 350K

| -19.59% | O: -3.72% H: 0.58% C: -3.82%
AZN | $68.38 -0.51% 2.1M

| 11.92% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $374.21 -0.55% 150K

| -3.4% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $264.955 -0.21% 880K

| -9.82% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

Global Sports Drink Market to Surpass Valuation of $32.89 Billion by 2030, with North America Dominating the Market as Demand for Sports Drinks with Natural Ingredients Increases, States Kings Research
Published: 2024-02-08 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 510

| -3.02% | O: 0.82% H: 0.0% C: 0.0%
TAP | $63.62 -1.78% 990K

Consumer Non-Durables

| 8.44% | O: 0.0% H: 0.97% C: 0.89%
HRL | $33.9 -0.03% 860K

Consumer Non-Durables

| 14.06% | O: -0.44% H: 0.61% C: -0.44%
GSK | $40.035 -1.15% 1.5M

| -3.62% | O: -0.48% H: 0.16% C: 0.0%
america natural research global market

Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
Published: 2024-02-08 (Crawled : 12:00) - globenewswire.com
GSK | $40.035 -1.15% 1.5M

| -3.62% | O: -0.48% H: 0.16% C: 0.0%
ALEC | $5.3 -6.03% 170K

| -11.88% | O: 0.0% H: 2.34% C: -2.34%
al101 first disease alzheimer’s trial

Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ | $0.0018 420K

| 157.14% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | $20.2 510

| -3.02% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | $92.966 630

| -0.76% | O: -1.64% H: 0.0% C: 0.0%
VTRS | $11.155 -1.46% 4.1M

| -3.58% | O: -0.34% H: 0.0% C: -1.2%
NVS | $92.99 -1.5% 990K

| -8.75% | O: -1.57% H: 0.26% C: -0.47%
GSK | $40.035 -1.15% 1.5M

| -3.62% | O: -0.48% H: 0.16% C: 0.0%
BAX | $39.79 -0.62% 1.3M

| 1.68% | O: -0.96% H: 5.91% C: 3.74%
ABT | $109.92 0.95% 3.2M

| -4.88% | O: -1.41% H: 0.0% C: 0.0%
SNY | $46.05 -0.41% 940K

| -0.59% | O: -2.25% H: 0.0% C: 0.0%
AMGN | $264.955 -0.21% 880K

| -10.26% | O: 0.38% H: 0.34% C: -0.72%
america growth market

23andMe Reports Third Quarter Fiscal 2024 Financial Results
Published: 2024-02-07 (Crawled : 21:00) - globenewswire.com
GSK | $40.035 -1.15% 1.5M

| -3.62% | O: -0.48% H: 0.16% C: 0.0%
financial results

FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
Published: 2024-02-07 (Crawled : 12:00) - globenewswire.com
GSK | $40.035 -1.15% 1.5M

| -2.99% | O: 0.43% H: 0.67% C: 0.21%
ALEC | $5.3 -6.03% 170K

| -6.62% | O: 2.15% H: 5.51% C: 3.73%
fda dementia designation grants therapy

Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | $135.94 770

| 1.57% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 82K

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
NVS | $92.99 -1.5% 990K

| -8.99% | O: 0.09% H: 0.39% C: -0.36%
GSK | $40.035 -1.15% 1.5M

| -2.99% | O: 0.43% H: 0.67% C: 0.21%
BAX | $39.79 -0.62% 1.3M

| 0.83% | O: 0.21% H: 0.24% C: -1.04%
ABBV | $162.93 0.78% 3.1M

| -5.47% | O: 1.48% H: 0.0% C: 0.0%
SNY | $46.05 -0.41% 940K

| 0.73% | O: 1.33% H: 0.0% C: 0.0%
BMRN S | $91.47 -0.04% 590K

| 1.9% | O: -0.38% H: 1.79% C: 0.22%
AZN | $68.38 -0.51% 2.1M

| 2.52% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $264.955 -0.21% 880K

| -16.0% | O: -0.18% H: 0.0% C: -6.22%
america therapeutics growth market

Heart Transplantation Therapeutics Market Projected for USD 135.37 Million Growth between 2024 and 2028: Market to Focus on Newer Techniques for Heart Transplantation - Technavio
Published: 2024-02-02 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.48 1.7K

| -21.33% | O: -3.89% H: 0.0% C: 0.0%
GLAXF | $20.2 510

| 1.0% | O: -0.7% H: 0.0% C: 0.0%
ALPMY | $9.2715 500K

| -19.73% | O: -4.76% H: 7.0% C: 3.18%
GSK | $40.035 -1.15% 1.5M

| -0.32% | O: -0.05% H: 0.59% C: 0.27%
ABBV | $162.93 0.78% 3.1M

| -1.19% | O: 3.59% H: 0.0% C: 0.0%
million heart therapeutics growth market

Vertigo Drugs Market Research Report 2023 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2018-2028F
Published: 2024-02-01 (Crawled : 18:00) - prnewswire.com
ENDPQ | $0.0018 420K

| 200.0% | O: -83.33% H: 500.0% C: 500.0%
GLAXF | $20.2 510

| 1.0% | O: -0.7% H: 0.0% C: 0.0%
NVS | $92.99 -1.5% 990K

| -10.37% | O: -0.5% H: 0.26% C: -1.03%
GSK | $40.035 -1.15% 1.5M

| -0.32% | O: -0.05% H: 0.59% C: 0.27%
report research global market

Global Sustained Release Coatings Markets, 2018-2022 and 2023-2028: Growing Demand for Controlled Drug Delivery Boosts Expansion
Published: 2024-02-01 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 510

| -1.68% | O: -1.29% H: 0.0% C: -1.38%
PFE A | $25.73 -0.7% 17M

| -4.32% | O: 0.07% H: 0.83% C: 0.7%
NVS | $92.99 -1.5% 990K

| -8.76% | O: 1.55% H: 0.79% C: 0.25%
GSK | $40.035 -1.15% 1.5M

| 2.69% | O: 1.27% H: 1.87% C: 1.73%
EMN | $96.45 -0.89% 370K

Process Industries

| 16.48% | O: 0.79% H: 0.8% C: 0.77%
drug expansion global growing

USD 2.1 billion growth in Weight Loss Supplement Market between 2022 and 2027, The growth of online retail stores to boost growth - 17,000+ Technavio Research Reports
Published: 2024-01-31 (Crawled : 05:00) - prnewswire.com
GLAXF | $20.2 510

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
GSK | $40.035 -1.15% 1.5M

| 3.61% | O: 4.04% H: 1.57% C: -3.02%
ABT | $109.92 0.95% 3.2M

| -4.17% | O: 0.33% H: 0.47% C: -0.75%
retail research growth market

Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-01-30 (Crawled : 23:00) - prnewswire.com
ALPMF | $9.48 1.7K

| -17.92% | O: 4.34% H: 0.0% C: 0.0%
GLAXF | $20.2 510

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $135.94 770

| 3.57% | O: 3.41% H: 0.0% C: -2.45%
ALPMY | $9.2715 500K

| -19.87% | O: 0.0% H: 1.38% C: 0.26%
VTRS | $11.155 -1.46% 4.1M

| -4.15% | O: -0.08% H: 3.47% C: -0.25%
NVS | $92.99 -1.5% 990K

| -12.38% | O: -2.04% H: 0.19% C: -1.97%
GSK | $40.035 -1.15% 1.5M

| 3.61% | O: 4.04% H: 1.57% C: -3.02%
ABBV | $162.93 0.78% 3.1M

| -1.97% | O: 0.5% H: 0.07% C: -0.81%
SNY | $46.05 -0.41% 940K

| -6.76% | O: 1.75% H: 0.0% C: 0.0%
AZN | $68.38 -0.51% 2.1M

| 2.28% | O: 0.82% H: 0.12% C: -1.64%
market

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 510

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $135.94 770

| 3.57% | O: 3.41% H: 0.0% C: -2.45%
VTRS | $11.155 -1.46% 4.1M

| -4.15% | O: -0.08% H: 3.47% C: -0.25%
NVS | $92.99 -1.5% 990K

| -12.38% | O: -2.04% H: 0.19% C: -1.97%
GSK | $40.035 -1.15% 1.5M

| 3.61% | O: 4.04% H: 1.57% C: -3.02%
ABBV | $162.93 0.78% 3.1M

| -1.97% | O: 0.5% H: 0.07% C: -0.81%
SNY | $46.05 -0.41% 940K

| -6.76% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $5.07 -5.23% 200K

| 12.28% | O: -0.1% H: 2.31% C: -1.26%
AZN | $68.38 -0.51% 2.1M

| 2.28% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $264.955 -0.21% 880K

| -15.61% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc and Amgen Inc to emerge as Some of the Key Companies - Technavio
Published: 2024-01-29 (Crawled : 00:00) - prnewswire.com
CMXHF | $180.75 33

| -8.13% | O: -1.84% H: 0.52% C: 0.52%
CSLLY | $89.5 44K

| -7.96% | O: -0.25% H: 1.0% C: 0.98%
ALPMF | $9.48 1.7K

| -16.48% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | $20.2 510

| 6.51% | O: 2.93% H: 0.0% C: -1.15%
AZNCF | $135.94 770

| 2.61% | O: 3.1% H: 0.0% C: -3.91%
ALPMY | $9.2715 500K

| -20.07% | O: -3.53% H: 3.49% C: 3.4%
TVTX | $6.185 -2.14% 390K

| -32.19% | O: -1.39% H: 0.16% C: -1.96%
GSK | $40.035 -1.15% 1.5M

| 3.69% | O: 0.26% H: 0.13% C: -0.18%
AZN | $68.38 -0.51% 2.1M

| 2.29% | O: 0.24% H: 0.01% C: -0.22%
AMGN | $264.955 -0.21% 880K

| -15.29% | O: -0.29% H: 0.76% C: 0.67%
companies renal anemia key therapeutics growth market

Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published: 2024-01-29 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.48 1.7K

| -16.48% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | $20.2 510

| 6.51% | O: 2.93% H: 0.0% C: -1.15%
ALPMY | $9.2715 500K

| -20.07% | O: -3.53% H: 3.49% C: 3.4%
NVS | $92.99 -1.5% 990K

| -12.54% | O: -0.59% H: 0.49% C: 0.41%
GSK | $40.035 -1.15% 1.5M

| 3.69% | O: 0.26% H: 0.13% C: -0.18%
ABBV | $162.93 0.78% 3.1M

| -1.37% | O: 0.19% H: 0.46% C: 0.43%
SNY | $46.05 -0.41% 940K

| -6.65% | O: 0.12% H: 0.0% C: 0.0%
kidney renal expected million therapeutics growth market

Antibacterial Drugs Market Report 2024-2034, Featuring Profiles of AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer & Sanofi
Published: 2024-01-26 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 510

| 2.46% | O: -1.67% H: 0.0% C: 0.0%
SNYNF | $92.966 630

| -6.33% | O: 1.8% H: 0.0% C: -1.82%
NVS | $92.99 -1.5% 990K

| -11.76% | O: 0.29% H: 0.15% C: -0.13%
JNJ | $145.405 -1.48% 7.6M

| -7.23% | O: 0.8% H: 0.0% C: 0.0%
GSK | $40.035 -1.15% 1.5M

| 4.27% | O: 1.36% H: 0.23% C: -0.76%
BMY | $48.365 -0.3% 4.9M

| -2.22% | O: 0.71% H: 0.48% C: -0.52%
ABBV | $162.93 0.78% 3.1M

| -1.37% | O: 0.85% H: 0.0% C: 0.0%
SNY | $46.05 -0.41% 940K

| -6.07% | O: 0.5% H: 0.0% C: 0.0%
report antibacterial sanofi market

Obsessive-Compulsive Disorder Drugs Market size worth USD 348.54 million, 55% Growth to Originate from North America - Technavio
Published: 2024-01-25 (Crawled : 06:00) - prnewswire.com
NVSEF | $93.6375 82K

| -14.09% | O: -3.67% H: 0.0% C: 0.0%
NVS | $92.99 -1.5% 990K

| -12.22% | O: -0.44% H: 0.19% C: -0.08%
GSK | $40.035 -1.15% 1.5M

| 3.77% | O: -0.23% H: 0.03% C: -0.26%
JAZZ | $110.22 -0.62% 310K

| -9.93% | O: 0.28% H: 0.36% C: -0.53%
BWAY | $5.12 -2.85% 39K

| -13.75% | O: 1.47% H: 0.65% C: -1.45%
america growth market

Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology
Published: 2024-01-24 (Crawled : 13:30) - biospace.com/
GSK | $40.035 -1.15% 1.5M

| 3.11% | O: 0.48% H: 0.66% C: -1.11%
collaboration dna technology agreement

Over-The-Counter Drug Market to Grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB as Key Market Contributors - 17000+ Technavio Reports
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
RBGPF | $51.8 8K

Consumer Non-Durables

| -27.29% | O: -1.75% H: 0.0% C: 0.0%
SNYNF | $92.966 630

| -9.83% | O: -3.01% H: 0.69% C: -0.75%
AZNCF | $135.94 770

| 0.77% | O: -0.42% H: 0.0% C: -1.8%
RBGLY | $10.49 5.1M

| -25.97% | O: -0.35% H: 0.07% C: -0.14%
NVS | $92.99 -1.5% 990K

| -12.36% | O: 0.22% H: 0.43% C: -0.39%
GSK | $40.035 -1.15% 1.5M

| 3.11% | O: 0.48% H: 0.66% C: -1.11%
ABT | $109.92 0.95% 3.2M

| -5.19% | O: -3.45% H: 0.0% C: 0.0%
SNY | $46.05 -0.41% 940K

| -6.41% | O: 0.92% H: 0.0% C: 0.0%
AZN | $68.38 -0.51% 2.1M